Heart Transplantation Clinical Trials

23 recruitingLast updated: June 18, 2026

There are 23 actively recruiting heart transplantation clinical trials across 12 countries. Studies span Phase 2, Not Applicable, Phase 1. Top locations include Vienna, State of Vienna, Austria, Bologna, Italy, Benevento, Italy. Updated daily from ClinicalTrials.gov.


Heart Transplantation Trials at a Glance

23 actively recruiting trials for heart transplantation are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Vienna, Bologna, and Benevento. Lead sponsors running heart transplantation studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Medical University of Vienna, and Fernando Bacal.

Browse heart transplantation trials by phase

Treatments under study

About Heart Transplantation Clinical Trials

Looking for clinical trials for Heart Transplantation? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Transplantation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting

CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation

Heart TransplantationRejection Heart TransplantHLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna683 enrolled4 locationsNCT06774365
Recruiting
Phase 2

Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation

Acute Kidney InjuryHeart Transplantation
Fernando Bacal74 enrolled1 locationNCT05909150
Recruiting

A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation

heart transplant rejectionHeart Transplantation
Karolinska Institutet120 enrolled1 locationNCT07531784
Recruiting

The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients

Heart Transplantation
National Institute of Cardiology, Laranjeiras, Brazil31 enrolled1 locationNCT05729009
Recruiting

Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease

Pediatric ALLCongenital Heart DiseaseHeart Transplantation
University of Alberta20 enrolled1 locationNCT06325280
Recruiting
Phase 2

Study of Organ Perfusion in Heart Transplantation in Children

Heart Transplantation
Dr. F. Köhler Chemie GmbH15 enrolled3 locationsNCT06032195
Recruiting

METABolic Deterioration in HTX Determines Outcomes

Heart Transplantation
Heinrich-Heine University, Duesseldorf270 enrolled1 locationNCT07372820
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

Pericoronary Adipocyte Size Gradient

Heart FailureHeart Transplantation
Institute for Clinical and Experimental Medicine60 enrolled1 locationNCT07360925
Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

Quality of LifePregnancyKidney Transplant+10 more
University Medical Center Groningen200 enrolled1 locationNCT07291258
Recruiting
Phase 2

Belatacept in De Novo Heart Transplantation

Heart Transplantation
NYU Langone Health12 enrolled2 locationsNCT04477629
Recruiting

Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery

Heart FailureArrhythmiaCardiac Arrest (CA)+6 more
Hochgebirgsklinik Davos10,000 enrolled1 locationNCT07096973
Recruiting

ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study

Myocardial InjuryOrgan PreservationHeart Transplantation+3 more
Medical University of Vienna50 enrolled1 locationNCT06982404
Recruiting
Not Applicable

Haemoadsorption During Heart Transplantation

Heart Transplantation
Medical University of Vienna40 enrolled1 locationNCT05270902
Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Sudden Cardiac Death+14 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna700 enrolled3 locationsNCT06813443
Recruiting
Phase 1Phase 2

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children

Heart Transplantation
Rafael Correa-Rocha11 enrolled1 locationNCT04924491
Recruiting

Electronic Register on Advanced Heart Failure and Transplantation di Cuore

Heart FailureHeart Transplantation
IRCCS Azienda Ospedaliero-Universitaria di Bologna10,000 enrolled1 locationNCT06773611
Recruiting

Precision Medicine in the Management of Heart Transplant Recipients

Heart Transplantation
IRCCS Azienda Ospedaliero-Universitaria di Bologna200 enrolled1 locationNCT06774794
Recruiting
Not Applicable

Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure

Heart FailureCardiomyopathy IschemicCatheter Ablation+3 more
Heart and Diabetes Center North-Rhine Westfalia160 enrolled1 locationNCT06556485